Epicutis®, a biotech skincare brand focused on patented biotechnology from Signum Biosciences, has appointed James Y. Wang, MD, MBA, as its new Chief Medical Officer. This announcement was made on October 5, 2026, as the company prepares for its next phase of growth. Dr. Wang has chaired the Epicutis Scientific Advisory Board since 2025.
Read More
In his new role, Dr. Wang will be responsible for leading the brand's medical and clinical strategy, guiding clinical research, and expanding educational initiatives for physicians and aesthetic professionals associated with Epicutis. He brings a wealth of expertise as a board-certified dermatologist and dermatopathologist, allowing him to integrate clinical insights with scientific rigor.
Dr. Wang is the founder of Metropolis Dermatology, which operates five locations in California and provides comprehensive dermatological services. He earned his medical degree from Harvard Medical School and an MBA from Harvard Business School. He completed his dermatology residency at UCLA and underwent advanced training in dermatopathology.
Epicutis products are exclusively available through professional channels, including dermatology practices, medical spas, and luxury hotel spas, as well as a growing network of wellness and longevity clinics. The brand's formulations are based on proprietary molecules created by scientists at Signum Biosciences, underpinned by over 15 years of peer-reviewed research published in journals such as the Journal of Investigative Dermatology and the Journal of Cosmetic Dermatology.
As the brand develops new technologies and expands into new markets, Dr. Wang's role will ensure that all products are backed by clinical evidence. Maxwell Stock, Founder and CEO of Epicutis and Signum Biosciences, emphasized the importance of Dr. Wang's appointment, stating that it places a practicing dermatologist in a central position in product development and clinical studies. Dr. Wang will also evaluate emerging research, inform clinical study designs, advise on product development, and lead educational programs to help healthcare providers utilize Epicutis products effectively.